Cellares Stock

www.cellares.com/Healthcare / Healthcare providers & servicesFounded: 2019Funding to Date: $330.75MM

Cellares, founded in 2019, is a cell therapy manufacturer that strives to develop scalable solutions to accelerate care for people living with a range of diseases. The company is the first Integrated Development and Manufacturing Organization (IDMO), and its Cell Shuttle platform aims to use automation to increase productivity at facilities that manufacture cell therapies for both autologous and allogeneic processes. Cellares is headquartered in San Francisco, California.

Register for Details

For more details on financing and valuation for Cellares, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cellares.

Register Today

Team

Management Team

Fabian Gerlinghaus
Co-Founder & Chief Executive Officer
Omar Kurdi
Co-Founder & President
Gary Lo
Chief Financial Officer

Board Members

Justin Butler
Eclipse Ventures
Victor Tong Jr.
Decheng Capital

Other companies like Cellares in the Healthcare providers & services sector

Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.39B
Sector
Last Round Est. Valuation
$5.7B
Sector
Last Round Est. Valuation
$37.8MM
Sector
Last Round Est. Valuation
$1.81B
Sector
Last Round Est. Valuation
$2.18B
Sector
Last Round Est. Valuation
$3.52B
Sector
Last Round Est. Valuation
$1.53B
Sector
Last Round Est. Valuation
$6.22B

News Highlights

Cellares unveils $255M investment round with Bristol Myers among those in the fold
Wednesday, Cellares revealed a $255 million series C investment round to complete construction of its commercial-scale cell therapy manufacturing facility in Bridgewater, New Jersey. The fresh funding follows an $82 million series B round in 2021 and brings total backing in the company to $355 million.
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.